Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA Assay in Detecting AChR and MuSK IgG of Myasthenia Gravis: a National Multicenter Study

NCT05219097 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.

NCT NCT05219097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05219097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA Assay in Detecting AChR and MuSK IgG of Myasthenia Gravis: a National Multicenter Study
Lead sponsor
Tianjin Medical University General Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
December 31, 2022
Enrollment
2,663 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

detection autoantibody of myasthenia gravis